Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer


Acquired | Acquired

About Scithera Microbial Technologies

Scithera Microbial Technologies is a biotechnology company.

Scithera Microbial Technologies Headquarter Location

East Lake High-tech Zone High Road Biotechnology Institute Building, 2nd Floor B7

Wuhan, Hubei,



Latest Scithera Microbial Technologies News

Phagelux announces purchase of Scithera Microbial Technologies’ key assets

Oct 14, 2015

Published on October 14, 2015 at 9:10 AM· No Comments Phagelux, Inc., a leading anti-bacterial company, is pleased to announce the purchase of the key assets of Scithera Microbial Technologies, Ltd., headquartered in Wuhan China, a pioneer in the research and development of lysin solutions for pathogen control in the field of human health. The assets purchased include intellectual property for multiple lysins and for the rapid development of lysin solutions. William Wang, COO for Phagelux and who led Phagelux in this acquisition, says "we are extremely excited to add this platform and these specific technologies to our growing array of anti-bacterial solutions. " Dr. Sixiang Zhou, Director of Business Development for Phagelux, added that "one of the main drivers for this acquisition was the strength of the Scithera scientific team that will join Phagelux. Simply put, Scithera has one of the strongest lysin development teams in the world. " The former Scithera scientific team will be located in new Phagelux laboratory facilities at the BioLake Science Park in Wuhan, China. Dr. Hongping Wei, President of Scithera says "we are very excited to join with Phagelux because we have high confidence in the capabilities of Phagelux to rapidly commercial our scientific achievements in China and globally. " Source:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.